Classification
Product TypeProcessed Food
Product FormCapsules (hard capsule) / softgel-style dose form
Industry PositionConsumer Packaged Goods (Food Supplement)
Market
In Germany, coenzyme Q10 is marketed primarily as a food supplement (Nahrungsergänzungsmittel) in dose form such as capsules, sold through drugstores, pharmacies, and online retail. Before first placing a food supplement on the German market, the responsible manufacturer or importer must notify the Federal Office of Consumer Protection and Food Safety (BVL) and submit a label specimen; there is no pre-market authorisation or approval by a authority. Product communication is a central constraint: EU nutrition and health-claim rules apply, and consumer authorities in Germany note that many Q10-related advertising claims reviewed by EFSA are classified as non-authorised (therefore not permitted). Retail formulations commonly range from vegan capsules (e.g., HPMC shells with simple carriers) to oil-based capsules using emulsifiers/humectants, making allergen and ingredient labelling a practical compliance focus.
Market RoleDomestic consumer market for CoQ10 food supplements under EU/German food law; market entry depends on BVL notification and compliant labelling/claims rather than a pre-market approval
Domestic RoleWidely marketed supplement ingredient and finished supplement product in dose form (capsules), sold via modern retail (drugstore) and pharmacy channels
Market Growth
SeasonalityYear-round retail availability; demand is not tied to agricultural harvest cycles.
Specification
Physical Attributes- Dose-form supplements marketed as hard capsules; both gelatin-based and vegan capsule shells (e.g., hydroxypropylmethylcellulose) are present in German retail listings.
Compositional Metrics- Label-declared CoQ10 content per daily dose (examples in German retail listings include 50 mg and 200 mg per capsule).
- NRV (% reference intake) is typically not applicable for CoQ10 on EU-style labels (often presented as ‘no NRV established’).
Packaging- Common retail pack sizes in German listings include 30-capsule and 120-capsule units.
Supply Chain
Value Chain- Ingredient sourcing (CoQ10) → incoming QC → blending/formulation (powder-based or oil-based) → encapsulation → packaging & labelling → distribution to drugstores/pharmacies/online → official controls/market surveillance by competent authorities
Temperature- Dry storage and avoidance of elevated temperature are typical label instructions (e.g., ‘do not store above 25°C’).
Freight IntensityLow
Transport ModeMultimodal
Risks
Regulatory Compliance HighNon-compliant health/medical advertising claims for CoQ10 can trigger enforcement actions (warnings, stop-sale, relabelling/withdrawal) because EU rules only allow authorised claims and the EU Register lists non-authorised claims; German consumer guidance notes that many EFSA-reviewed Q10 claims are classified as non-authorised and therefore not permitted.Use only claims that are explicitly authorised under Regulation (EC) No 1924/2006 and verified in the EU Register; implement pre-publication claim review for labels, websites, marketplaces, and influencer content.
Documentation Gap MediumFailure to complete the mandatory German notification to the BVL (including providing a label specimen) at first placing on the market can disrupt listing, distribution, and official-control interactions even though no pre-market approval exists.Complete BVL online notification prior to launch and maintain an internal dossier with the exact label version submitted and subsequent change history.
Food Safety MediumGermany consumer guidance flags potential adverse effects at high dosages and interaction concerns (e.g., with anticoagulants and other therapies), increasing sensitivity to product presentation and responsible-use messaging even though supplements are not medicines.Apply conservative consumer warnings consistent with general food-law obligations and ensure any interaction-related statements do not imply disease treatment; refer consumers to healthcare professionals where appropriate.
Labeling MediumFormulations may include allergens (e.g., soybean oil/lecithins) or animal-derived gelatin in some products, creating a recurring allergen/ingredient labelling risk under EU food information rules.Maintain a controlled ingredient/allergen specification for each SKU and verify that the ingredient list and allergen statements align with Regulation (EU) No 1169/2011 requirements for the German market.
Sustainability- Upstream supplier environmental management for industrial CoQ10 production (e.g., chemical/fermentation processing inputs) may be requested in retailer/supplier audits, but requirements vary by buyer.
FAQ
Do coenzyme Q10 food supplements need pre-market authorisation in Germany?No. In Germany, food supplements do not undergo a pre-market approval by an authority, but the manufacturer or importer must notify the BVL no later than first placing the product on the German market and submit a label specimen.
Can coenzyme Q10 supplements be advertised with broad health benefits in Germany?Only if the claim is permitted under EU nutrition and health-claim rules and aligns with the EU Register. German consumer guidance notes that many Q10-related advertising claims reviewed by EFSA have the status “non-authorised,” meaning they are not allowed as health claims.
What ingredients commonly appear in coenzyme Q10 capsules sold in German retail listings?Examples in German drugstore listings include vegan capsules with hydroxypropylmethylcellulose and rice flour, as well as oil-based capsules using ingredients such as soybean oil, gelatin, glycerin, sorbitol, lecithins, and emulsifiers; products containing soy must declare the allergen on the label under EU food information rules.